Listed

Nuvation Bio Inc.

NUVBNYSECIK 1811063HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$31.7m, Q2 FY2026
Operating income−$51.0m, Q2 FY2026
Net income−$62.8m, Q2 FY2026
Nuvation Bio Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-06, accession 0000950170-25-034903. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure1.4Revenue, Q2 FY2024, three months to 2024-06-30$1.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure0.7Revenue, Q3 FY2024, three months to 2024-09-30$727.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure5.7Revenue, Q4 FY2024, three months to 2024-12-31$5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure3.1Revenue, Q1 FY2025, three months to 2025-03-31$3.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure4.8Revenue, Q2 FY2025, three months to 2025-06-30$4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure13.1Revenue, Q3 FY2025, three months to 2025-09-30$13.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure41.9Revenue, Q4 FY2025, three months to 2025-12-31$41.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure83.2Revenue, Q1 FY2026, three months to 2026-03-31$83.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure31.7Revenue, Q2 FY2026, three months to 2026-06-30$31.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Cost of revenue$mnot reportednot reported0.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure1.3Cost of revenue, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure1.5Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure4.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$4.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-06, accession 0000950170-25-034903. Derived: 12-month figure less the 9-month figure.Report this figure2.1Cost of revenue, Q1 FY2025, three months to 2025-03-31$2.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure2.6Cost of revenue, Q2 FY2025, three months to 2025-06-30$2.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure3.3Cost of revenue, Q3 FY2025, three months to 2025-09-30$3.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figurenot reportednot reportednot reported
Gross profit$m0.0Gross profit, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure0.0Gross profit, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-06, accession 0000950170-25-034903. Derived: 12-month figure less the 9-month figure.Report this figure0.0Gross profit, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure0.1Gross profit, Q2 FY2024, three months to 2024-06-30$88.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure(0.8)Gross profit, Q3 FY2024, three months to 2024-09-30−$788.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure1.5Gross profit, Q4 FY2024, three months to 2024-12-31$1.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-06, accession 0000950170-25-034903. Derived: 12-month figure less the 9-month figure.Report this figure1.0Gross profit, Q1 FY2025, three months to 2025-03-31$990.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure2.3Gross profit, Q2 FY2025, three months to 2025-06-30$2.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure9.8Gross profit, Q3 FY2025, three months to 2025-09-30$9.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figurenot reportednot reportednot reported
Research and development$m18.6Research and development, Q3 FY2023, three months to 2023-09-30$18.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure15.4Research and development, Q4 FY2023, three months to 2023-12-31$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0000950170-25-034903. Derived: 12-month figure less the 9-month figure.Report this figure12.8Research and development, Q1 FY2024, three months to 2024-03-31$12.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure29.2Research and development, Q2 FY2024, three months to 2024-06-30$29.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure27.7Research and development, Q3 FY2024, three months to 2024-09-30$27.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure29.3Research and development, Q4 FY2024, three months to 2024-12-31$29.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure24.6Research and development, Q1 FY2025, three months to 2025-03-31$24.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure27.4Research and development, Q2 FY2025, three months to 2025-06-30$27.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure28.8Research and development, Q3 FY2025, three months to 2025-09-30$28.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure34.3Research and development, Q4 FY2025, three months to 2025-12-31$34.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure35.0Research and development, Q1 FY2026, three months to 2026-03-31$35.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure30.7Research and development, Q2 FY2026, three months to 2026-06-30$30.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Selling, general and administrative$m7.8Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$7.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure5.5Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$5.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-06, accession 0000950170-25-034903. Derived: 12-month figure less the 9-month figure.Report this figure7.4Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$7.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure16.2Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$16.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure19.6Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$19.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure26.1Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$26.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure35.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$35.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure38.5Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$38.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure37.4Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$37.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure40.3Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$40.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure38.3Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$38.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure42.6Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$42.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Operating income$m(26.3)Operating income, Q3 FY2023, three months to 2023-09-30−$26.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure(20.8)Operating income, Q4 FY2023, three months to 2023-12-31−$20.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034903. Derived: 12-month figure less the 9-month figure.Report this figure(20.2)Operating income, Q1 FY2024, three months to 2024-03-31−$20.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure(470)Operating income, Q2 FY2024, three months to 2024-06-30−$470.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure(48.1)Operating income, Q3 FY2024, three months to 2024-09-30−$48.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure(53.9)Operating income, Q4 FY2024, three months to 2024-12-31−$53.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure(59.0)Operating income, Q1 FY2025, three months to 2025-03-31−$59.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure(63.6)Operating income, Q2 FY2025, three months to 2025-06-30−$63.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure(56.4)Operating income, Q3 FY2025, three months to 2025-09-30−$56.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure(34.0)Operating income, Q4 FY2025, three months to 2025-12-31−$34.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure3.9Operating income, Q1 FY2026, three months to 2026-03-31$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure(51.0)Operating income, Q2 FY2026, three months to 2026-06-30−$51.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-03-06, accession 0000950170-25-034903. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure0.1Interest expense, Q2 FY2024, three months to 2024-06-30$132.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-05, accession 0000950170-24-090347.Report this figure0.1Interest expense, Q3 FY2024, three months to 2024-09-30$120.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure0.1Interest expense, Q4 FY2024, three months to 2024-12-31$89.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2025, three months to 2025-03-31$54.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure0.4Interest expense, Q2 FY2025, three months to 2025-06-30$421.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure5.1Interest expense, Q3 FY2025, three months to 2025-09-30$5.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure5.0Interest expense, Q2 FY2025, three months to 2025-12-31$5.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 6-month figure less the 3-month figure.Report this figure6.7Interest expense, Q1 FY2026, three months to 2026-03-31$6.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure6.8Interest expense, Q2 FY2026, three months to 2026-06-30$6.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-06, accession 0000950170-25-034903. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Net income$m(19.6)Net income, Q3 FY2023, three months to 2023-09-30−$19.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure(13.8)Net income, Q4 FY2023, three months to 2023-12-31−$13.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034903. Derived: 12-month figure less the 9-month figure.Report this figure(14.8)Net income, Q1 FY2024, three months to 2024-03-31−$14.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure(462)Net income, Q2 FY2024, three months to 2024-06-30−$462.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure(41.2)Net income, Q3 FY2024, three months to 2024-09-30−$41.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure(49.4)Net income, Q4 FY2024, three months to 2024-12-31−$49.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure(53.2)Net income, Q1 FY2025, three months to 2025-03-31−$53.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure(59.0)Net income, Q2 FY2025, three months to 2025-06-30−$59.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure(55.8)Net income, Q3 FY2025, three months to 2025-09-30−$55.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure(36.6)Net income, Q4 FY2025, three months to 2025-12-31−$36.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure5.4Net income, Q1 FY2026, three months to 2026-03-31$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure(62.8)Net income, Q2 FY2026, three months to 2026-06-30−$62.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Diluted EPS$ per share(0.09)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figurenot reported(0.07)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure(1.89)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.89 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure(0.15)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figurenot reported(0.16)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure(0.17)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure(0.16)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figurenot reported0.01Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure(0.18)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Basic EPS$ per share(0.09)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figurenot reported(0.07)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure(1.89)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.89 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure(0.15)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figurenot reported(0.16)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure(0.17)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure(0.16)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figurenot reported0.02Basic EPS, Q1 FY2026, three months to 2026-03-31$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure(0.18)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure

Balance sheet

Cash and equivalents$258.6m, Q2 FY2026
Long-term debt$242.6m, Q2 FY2026
Shareholders' equity$253.9m, Q2 FY2026
Nuvation Bio Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m24.4Cash and equivalents, Q3 FY2023, at 2023-09-30$24.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-02, accession 0000950170-23-058253.Report this figure42.6Cash and equivalents, FY2023, at 2023-12-31$42.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0000950170-25-034903.Report this figure34.5Cash and equivalents, Q1 FY2024, at 2024-03-31$34.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0000950170-24-059622.Report this figure34.3Cash and equivalents, Q2 FY2024, at 2024-06-30$34.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-05, accession 0000950170-24-090347.Report this figure30.0Cash and equivalents, Q3 FY2024, at 2024-09-30$30.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure35.7Cash and equivalents, FY2024, at 2024-12-31$35.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-02, accession 0001193125-26-085584.Report this figure48.0Cash and equivalents, Q1 FY2025, at 2025-03-31$48.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure248Cash and equivalents, Q2 FY2025, at 2025-06-30$248.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure98.9Cash and equivalents, Q3 FY2025, at 2025-09-30$98.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure164Cash and equivalents, FY2025, at 2025-12-31$164.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure125Cash and equivalents, Q1 FY2026, at 2026-03-31$125.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure259Cash and equivalents, Q2 FY2026, at 2026-06-30$258.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Current assets$m625Current assets, Q3 FY2023, at 2023-09-30$625.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058253.Report this figure616Current assets, FY2023, at 2023-12-31$616.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034903.Report this figure608Current assets, Q1 FY2024, at 2024-03-31$608.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059622.Report this figure587Current assets, Q2 FY2024, at 2024-06-30$587.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-05, accession 0000950170-24-090347.Report this figure565Current assets, Q3 FY2024, at 2024-09-30$565.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure526Current assets, FY2024, at 2024-12-31$526.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-02, accession 0001193125-26-085584.Report this figure476Current assets, Q1 FY2025, at 2025-03-31$475.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure623Current assets, Q2 FY2025, at 2025-06-30$623.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure578Current assets, Q3 FY2025, at 2025-09-30$577.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure572Current assets, FY2025, at 2025-12-31$571.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure592Current assets, Q1 FY2026, at 2026-03-31$591.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure726Current assets, Q2 FY2026, at 2026-06-30$726.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Total assets$m631Total assets, Q3 FY2023, at 2023-09-30$630.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0000950170-23-058253.Report this figure621Total assets, FY2023, at 2023-12-31$621.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0000950170-25-034903.Report this figure613Total assets, Q1 FY2024, at 2024-03-31$613.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059622.Report this figure595Total assets, Q2 FY2024, at 2024-06-30$594.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-05, accession 0000950170-24-090347.Report this figure572Total assets, Q3 FY2024, at 2024-09-30$571.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure541Total assets, FY2024, at 2024-12-31$540.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-02, accession 0001193125-26-085584.Report this figure492Total assets, Q1 FY2025, at 2025-03-31$492.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure647Total assets, Q2 FY2025, at 2025-06-30$647.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure602Total assets, Q3 FY2025, at 2025-09-30$601.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure595Total assets, FY2025, at 2025-12-31$594.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure610Total assets, Q1 FY2026, at 2026-03-31$610.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure745Total assets, Q2 FY2026, at 2026-06-30$744.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Current liabilities$m16.1Current liabilities, Q3 FY2023, at 2023-09-30$16.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058253.Report this figure14.0Current liabilities, FY2023, at 2023-12-31$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034903.Report this figure15.8Current liabilities, Q1 FY2024, at 2024-03-31$15.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059622.Report this figure51.1Current liabilities, Q2 FY2024, at 2024-06-30$51.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-05, accession 0000950170-24-090347.Report this figure59.0Current liabilities, Q3 FY2024, at 2024-09-30$59.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure58.2Current liabilities, FY2024, at 2024-12-31$58.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-02, accession 0001193125-26-085584.Report this figure52.8Current liabilities, Q1 FY2025, at 2025-03-31$52.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure66.4Current liabilities, Q2 FY2025, at 2025-06-30$66.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure68.1Current liabilities, Q3 FY2025, at 2025-09-30$68.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure82.2Current liabilities, FY2025, at 2025-12-31$82.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure79.5Current liabilities, Q1 FY2026, at 2026-03-31$79.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure86.8Current liabilities, Q2 FY2026, at 2026-06-30$86.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Total liabilities$m19.3Total liabilities, Q3 FY2023, at 2023-09-30$19.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0000950170-23-058253.Report this figure16.4Total liabilities, FY2023, at 2023-12-31$16.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0000950170-25-034903.Report this figure19.1Total liabilities, Q1 FY2024, at 2024-03-31$19.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059622.Report this figure62.7Total liabilities, Q2 FY2024, at 2024-06-30$62.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-05, accession 0000950170-24-090347.Report this figure68.9Total liabilities, Q3 FY2024, at 2024-09-30$68.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure76.8Total liabilities, FY2024, at 2024-12-31$76.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-02, accession 0001193125-26-085584.Report this figure73.0Total liabilities, Q1 FY2025, at 2025-03-31$73.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure274Total liabilities, Q2 FY2025, at 2025-06-30$274.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure276Total liabilities, Q3 FY2025, at 2025-09-30$275.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure289Total liabilities, FY2025, at 2025-12-31$289.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure291Total liabilities, Q1 FY2026, at 2026-03-31$290.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure491Total liabilities, Q2 FY2026, at 2026-06-30$490.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported47.0Long-term debt, Q2 FY2025, at 2025-06-30$47.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure47.1Long-term debt, Q3 FY2025, at 2025-09-30$47.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure47.2Long-term debt, FY2025, at 2025-12-31$47.2m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-02, accession 0001193125-26-085584.Report this figure47.3Long-term debt, Q1 FY2026, at 2026-03-31$47.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure243Long-term debt, Q2 FY2026, at 2026-06-30$242.6m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Short-term borrowings$mnot reported0.0Short-term borrowings, FY2023, at 2023-12-31$0. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2025-03-06, accession 0000950170-25-034903.Report this figurenot reported11.6Short-term borrowings, Q2 FY2024, at 2024-06-30$11.6m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-08-05, accession 0000950170-24-090347.Report this figure8.4Short-term borrowings, Q3 FY2024, at 2024-09-30$8.4m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure6.3Short-term borrowings, FY2024, at 2024-12-31$6.3m. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2026-03-02, accession 0001193125-26-085584.Report this figure5.7Short-term borrowings, Q1 FY2025, at 2025-03-31$5.7m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure5.6Short-term borrowings, Q2 FY2025, at 2025-06-30$5.6m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure5.6Short-term borrowings, Q3 FY2025, at 2025-09-30$5.6m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure5.7Short-term borrowings, FY2025, at 2025-12-31$5.7m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure5.8Short-term borrowings, Q1 FY2026, at 2026-03-31$5.8m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure5.9Short-term borrowings, Q2 FY2026, at 2026-06-30$5.9m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure
Shareholders' equity$m612Shareholders' equity, Q3 FY2023, at 2023-09-30$611.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure605Shareholders' equity, FY2023, at 2023-12-31$605.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-02, accession 0001193125-26-085584.Report this figure594Shareholders' equity, Q1 FY2024, at 2024-03-31$594.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure257Shareholders' equity, Q2 FY2024, at 2024-06-30$257.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure503Shareholders' equity, Q3 FY2024, at 2024-09-30$502.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure464Shareholders' equity, FY2024, at 2024-12-31$463.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure419Shareholders' equity, Q1 FY2025, at 2025-03-31$419.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure373Shareholders' equity, Q2 FY2025, at 2025-06-30$372.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure326Shareholders' equity, Q3 FY2025, at 2025-09-30$325.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure306Shareholders' equity, FY2025, at 2025-12-31$305.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure320Shareholders' equity, Q1 FY2026, at 2026-03-31$319.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure254Shareholders' equity, Q2 FY2026, at 2026-06-30$253.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure

Cash flow

Operating cash flow−$43.0m, Q2 FY2026
Nuvation Bio Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(16.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$16.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122402. Derived: 9-month figure less the 6-month figure.Report this figure(15.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$15.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0000950170-25-034903. Derived: 12-month figure less the 9-month figure.Report this figure(15.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure(37.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$37.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104626. Derived: 6-month figure less the 3-month figure.Report this figure(31.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$31.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001193125-25-262605. Derived: 9-month figure less the 6-month figure.Report this figure(46.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$46.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure(42.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$42.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure(48.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$48.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336646. Derived: 6-month figure less the 3-month figure.Report this figure(52.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$52.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001193125-25-262605. Derived: 9-month figure less the 6-month figure.Report this figure(29.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$29.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001193125-26-085584. Derived: 12-month figure less the 9-month figure.Report this figure5.1Operating cash flow, Q1 FY2026, three months to 2026-03-31$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure(43.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$43.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336646. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)348,770, Q2 FY2026
Nuvation Bio Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)k shares218Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30218,300 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0000950170-23-058253.Report this figure219Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31218,741 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059622.Report this figure219Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30218,848 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-05, accession 0000950170-24-090347.Report this figure219Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30218,935 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122402.Report this figure219Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31219,048 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0000950170-25-065712.Report this figure245Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30244,738 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-104626.Report this figure274Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30273,565 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure339Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31338,612 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure341Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30340,746 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure342Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30342,393 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001193125-25-262605.Report this figure378Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31377,521 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001193125-26-203964.Report this figure349Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30348,770 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure

Shares outstanding: 351.12mShares outstanding, period not labelled, at 2026-08-03351,123,233 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336646.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.